Peter from Janoshik gives another revealing interview

Appreciate the post.

Also pretty alarming: 1 in 20 or 1 in 25 tests come back as the wrong peptide. That is 4%-5% of every sample. It shows exactly why testing matters so much.
 
Toward the conclusion of the interview, he mentions that the majority of samples lacking any peptide are NOT being submitted by individual researchers such as ourselves. According to him, it's distributors who send in 50 samples at one time while looking for new suppliers. He further notes that this distorts the 1 in 20 figure.

Truly an excellent interview. Appreciate you sharing it.
 
Hearing that the announced molecule has a 4-5% defect rate is quite a revelation. It underscores how much the dependability of the source—the retailer—really matters. Scammers certainly exist, though fortunately GLP1Chat is around ;-)

His remarks on purity measurements—both what he states and what he leaves out—are also worth noting. I get that there's a marketing rationale behind showing a pseudo-precision of 4 digits (recent COAs have even shown 5 digits). If Janoshik were to say, “There is a 95% probability that the purity is between 99.2% and 100.2%” rather than 99.712%, they would probably need to bring on an entire customer support team just to handle the “I don’t get it!” responses.

What I wish he had addressed is the actual number of batches in circulation. I've pinpointed 6 factories in China that manufacture solid-phase peptides. There could be a handful more, but my guess is we'll land somewhere between 10 and 20. And they're nowhere near putting out a batch daily (some sellers are still sitting on batches from a year ago). Given all the resellers and customers running tests, I'd wager each batch gets tested dozens or even hundreds of times. After all, he needs his business to grow, and the source factories would prefer not to be traced by batch numbers. The whole arrangement functions well this way; I hope it can continue for a few more years.
 
This interview was quite informative, and it's clear that his influence touches every corner of the grey markets.

The short version:

Topics covered:

🔬 Janoshik's actual function

– The largest commercial analytical chemistry lab globally focused on hormones and peptides– More than 20,000 sq ft, 40+ staff, and now handling 1,000+ samples daily

– Began naturally from a dorm room at age 16 with no marketing or investors– Expanded by 50% in just the last three months

⚠️ What your peptides really contain

– About 1 in 20 samples is either the incorrect compound or dosed so low it's ineffective– A recent spike in totally empty vials with no active compound at all

– This impacts all peptides: BPC, GHK, Sema, Reta, and others

– Empty vials mostly originate from distributors screening new suppliers and typically never make it to consumers

– "Bioglutide," a wholly invented molecule, is still being sold and invariably tests as something different📊 Key testing priorities

– Identity and dose: by far the most valuable tests available

– Heavy metals: almost never a problem in peptides, so don't be swayed by fearmongering

– Endotoxins: once thought unnecessary, but recent contaminated batches causing local reactions have shifted that perspective

– 100% purity is physically impossible; anyone claiming it relies on dubious methods

– Pharma standard for HGH is 89% purity, while market standard ranges from 92–96%

đź’‰ The HGH situation

– HGH consists of 191 amino acids, making it far more complex and harder to maintain purity than short-chain peptides

– HGH testing over 99% pure does exist, but it's exceedingly uncommon

– Branded ampoules like Bayer Primobolan test as pure oil more than 90% of the time, with counterfeiting that's nearly flawless

🌍 Revenue sources

– Around 2/3 of revenue comes from the US, the largest consumer market and peptide culture

– About 20% from Chinese manufacturers using Janoshik to verify their own products

– Over 60,000 individual US clients compared to roughly 50 large Chinese manufacturers🧪 Why legal peptide testing is impossible in the US

– HGH and many peptides are scheduled substances requiring a DEA license

– Labs without proper licensing face legal liability

– GLP-1s can currently be tested in the US, but most small US labs still make mistakes

đź’ˇ Straight talk

– Testing transformed the steroid market within 5 years, and the same is now happening with peptides

– Companies that test consistently turn out better products; it's more cost-effective long-term than rebranding after setbacks

– Spend a bit more on companies that genuinely test their batches; it pays off

🧪 This isn't theoretical; it's real-world experience from working with hundreds of people and observing what truly works.
 
He mentioned near the end that his business volume grew 50% over the last 3 months?! Wow. I'm sure other factors are at play, but could the BPI/ProRX shutdowns have contributed? The timing lines up. Are enough people worried about losing access and switching to gray?

He also noted that the US accounts for MOST of his business. Some meds he can't legally test in the US came up, but he can test others here, such as GLPs. I'd think they'd want to move part of their operation stateside.
 
Skidude said:

This interview was quite informative, and it's clear that his influence touches every corner of the grey markets.

The short version:

Topics covered:

🔬 Janoshik's actual function

– The largest commercial analytical chemistry lab globally focused on hormones and peptides– More than 20,000 sq ft, 40+ staff, and now handling 1,000+ samples daily

– Began naturally from a dorm room at age 16 with no marketing or investors– Expanded by 50% in just the last three months

⚠️ What your peptides really contain

– About 1 in 20 samples is either the incorrect compound or dosed so low it's ineffective– A recent spike in totally empty vials with no active compound at all

– This impacts all peptides: BPC, GHK, Sema, Reta, and others

– Empty vials mostly originate from distributors screening new suppliers and typically never make it to consumers

– "Bioglutide," a wholly invented molecule, is still being sold and invariably tests as something different📊 Key testing priorities

– Identity and dose: by far the most valuable tests available

– Heavy metals: almost never a problem in peptides, so don't be swayed by fearmongering

– Endotoxins: once thought unnecessary, but recent contaminated batches causing local reactions have shifted that perspective

– 100% purity is physically impossible; anyone claiming it relies on dubious methods

– Pharma standard for HGH is 89% purity, while market standard ranges from 92–96%

đź’‰ The HGH situation

– HGH consists of 191 amino acids, making it far more complex and harder to maintain purity than short-chain peptides

– HGH testing over 99% pure does exist, but it's exceedingly uncommon

– Branded ampoules like Bayer Primobolan test as pure oil more than 90% of the time, with counterfeiting that's nearly flawless

🌍 Revenue sources

– Around 2/3 of revenue comes from the US, the largest consumer market and peptide culture

– About 20% from Chinese manufacturers using Janoshik to verify their own products

– Over 60,000 individual US clients compared to roughly 50 large Chinese manufacturers🧪 Why legal peptide testing is impossible in the US

– HGH and many peptides are scheduled substances requiring a DEA license

– Labs without proper licensing face legal liability

– GLP-1s can currently be tested in the US, but most small US labs still make mistakes

đź’ˇ Straight talk

– Testing transformed the steroid market within 5 years, and the same is now happening with peptides

– Companies that test consistently turn out better products; it's more cost-effective long-term than rebranding after setbacks

– Spend a bit more on companies that genuinely test their batches; it pays off

🧪 This isn't theoretical; it's real-world experience from working with hundreds of people and observing what truly works.
Click to expand...
Thanks so much!
 
Skidude said:

This interview was quite informative, and it's clear that his influence touches every corner of the grey markets.

The short version:

Topics covered:

🔬 Janoshik's actual function

– The largest commercial analytical chemistry lab globally focused on hormones and peptides– More than 20,000 sq ft, 40+ staff, and now handling 1,000+ samples daily

– Began naturally from a dorm room at age 16 with no marketing or investors– Expanded by 50% in just the last three months

⚠️ What your peptides really contain

– About 1 in 20 samples is either the incorrect compound or dosed so low it's ineffective– A recent spike in totally empty vials with no active compound at all

– This impacts all peptides: BPC, GHK, Sema, Reta, and others

– Empty vials mostly originate from distributors screening new suppliers and typically never make it to consumers

– "Bioglutide," a wholly invented molecule, is still being sold and invariably tests as something different📊 Key testing priorities

– Identity and dose: by far the most valuable tests available

– Heavy metals: almost never a problem in peptides, so don't be swayed by fearmongering

– Endotoxins: once thought unnecessary, but recent contaminated batches causing local reactions have shifted that perspective

– 100% purity is physically impossible; anyone claiming it relies on dubious methods

– Pharma standard for HGH is 89% purity, while market standard ranges from 92–96%

đź’‰ The HGH situation

– HGH consists of 191 amino acids, making it far more complex and harder to maintain purity than short-chain peptides

– HGH testing over 99% pure does exist, but it's exceedingly uncommon

– Branded ampoules like Bayer Primobolan test as pure oil more than 90% of the time, with counterfeiting that's nearly flawless

🌍 Revenue sources

– Around 2/3 of revenue comes from the US, the largest consumer market and peptide culture

– About 20% from Chinese manufacturers using Janoshik to verify their own products

– Over 60,000 individual US clients compared to roughly 50 large Chinese manufacturers🧪 Why legal peptide testing is impossible in the US

– HGH and many peptides are scheduled substances requiring a DEA license

– Labs without proper licensing face legal liability

– GLP-1s can currently be tested in the US, but most small US labs still make mistakes

đź’ˇ Straight talk

– Testing transformed the steroid market within 5 years, and the same is now happening with peptides

– Companies that test consistently turn out better products; it's more cost-effective long-term than rebranding after setbacks

– Spend a bit more on companies that genuinely test their batches; it pays off

🧪 This isn't theoretical; it's real-world experience from working with hundreds of people and observing what truly works.
Click to expand...
There is also a chance that distributors are testing Janoshik in return - slipping 1 or 2 blank vials into the shipment simply to see whether he notices.
 
bogardbilla said:

Skidude said:

This interview was quite informative, and it's clear that his influence touches every corner of the grey markets.

The short version:

Topics covered:

🔬 Janoshik's actual function

– The largest commercial analytical chemistry lab globally focused on hormones and peptides– More than 20,000 sq ft, 40+ staff, and now handling 1,000+ samples daily

– Began naturally from a dorm room at age 16 with no marketing or investors– Expanded by 50% in just the last three months

⚠️ What your peptides really contain

– About 1 in 20 samples is either the incorrect compound or dosed so low it's ineffective– A recent spike in totally empty vials with no active compound at all

– This impacts all peptides: BPC, GHK, Sema, Reta, and others

– Empty vials mostly originate from distributors screening new suppliers and typically never make it to consumers

– "Bioglutide," a wholly invented molecule, is still being sold and invariably tests as something different📊 Key testing priorities

– Identity and dose: by far the most valuable tests available

– Heavy metals: almost never a problem in peptides, so don't be swayed by fearmongering

– Endotoxins: once thought unnecessary, but recent contaminated batches causing local reactions have shifted that perspective

– 100% purity is physically impossible; anyone claiming it relies on dubious methods

– Pharma standard for HGH is 89% purity, while market standard ranges from 92–96%

đź’‰ The HGH situation

– HGH consists of 191 amino acids, making it far more complex and harder to maintain purity than short-chain peptides

– HGH testing over 99% pure does exist, but it's exceedingly uncommon

– Branded ampoules like Bayer Primobolan test as pure oil more than 90% of the time, with counterfeiting that's nearly flawless

🌍 Revenue sources

– Around 2/3 of revenue comes from the US, the largest consumer market and peptide culture

– About 20% from Chinese manufacturers using Janoshik to verify their own products

– Over 60,000 individual US clients compared to roughly 50 large Chinese manufacturers🧪 Why legal peptide testing is impossible in the US

– HGH and many peptides are scheduled substances requiring a DEA license

– Labs without proper licensing face legal liability

– GLP-1s can currently be tested in the US, but most small US labs still make mistakes

đź’ˇ Straight talk

– Testing transformed the steroid market within 5 years, and the same is now happening with peptides

– Companies that test consistently turn out better products; it's more cost-effective long-term than rebranding after setbacks

– Spend a bit more on companies that genuinely test their batches; it pays off

🧪 This isn't theoretical; it's real-world experience from working with hundreds of people and observing what truly works.
Click to expand...
There is also a chance that distributors are testing Janoshik in return - slipping 1 or 2 blank vials into the shipment simply to see whether he notices.
Click to expand...
That said, I wouldn't dismiss the idea entirely. Still, given that Jano serves as the benchmark for refunds and functions as the industry-wide standard, I'd put the odds at very low.
 
Skidude said:

This interview was quite informative, and it's clear that his influence touches every corner of the grey markets.

The short version:

Topics covered:

🔬 Janoshik's actual function

– The largest commercial analytical chemistry lab globally focused on hormones and peptides– More than 20,000 sq ft, 40+ staff, and now handling 1,000+ samples daily

– Began naturally from a dorm room at age 16 with no marketing or investors– Expanded by 50% in just the last three months

⚠️ What your peptides really contain

– About 1 in 20 samples is either the incorrect compound or dosed so low it's ineffective– A recent spike in totally empty vials with no active compound at all

– This impacts all peptides: BPC, GHK, Sema, Reta, and others

– Empty vials mostly originate from distributors screening new suppliers and typically never make it to consumers

– "Bioglutide," a wholly invented molecule, is still being sold and invariably tests as something different📊 Key testing priorities

– Identity and dose: by far the most valuable tests available

– Heavy metals: almost never a problem in peptides, so don't be swayed by fearmongering

– Endotoxins: once thought unnecessary, but recent contaminated batches causing local reactions have shifted that perspective

– 100% purity is physically impossible; anyone claiming it relies on dubious methods

– Pharma standard for HGH is 89% purity, while market standard ranges from 92–96%

đź’‰ The HGH situation

– HGH consists of 191 amino acids, making it far more complex and harder to maintain purity than short-chain peptides

– HGH testing over 99% pure does exist, but it's exceedingly uncommon

– Branded ampoules like Bayer Primobolan test as pure oil more than 90% of the time, with counterfeiting that's nearly flawless

🌍 Revenue sources

– Around 2/3 of revenue comes from the US, the largest consumer market and peptide culture

– About 20% from Chinese manufacturers using Janoshik to verify their own products

– Over 60,000 individual US clients compared to roughly 50 large Chinese manufacturers🧪 Why legal peptide testing is impossible in the US

– HGH and many peptides are scheduled substances requiring a DEA license

– Labs without proper licensing face legal liability

– GLP-1s can currently be tested in the US, but most small US labs still make mistakes

đź’ˇ Straight talk

– Testing transformed the steroid market within 5 years, and the same is now happening with peptides

– Companies that test consistently turn out better products; it's more cost-effective long-term than rebranding after setbacks

– Spend a bit more on companies that genuinely test their batches; it pays off

🧪 This isn't theoretical; it's real-world experience from working with hundreds of people and observing what truly works.
Click to expand...

I appreciate you sharing this.
 
lastresort said:

Honestly, I'd love to be on their payroll and earn that kind of money
Click to expand...

That's right! According to Peter, retirement was an option he could have taken long ago, yet he continues because he enjoys his work.

In my view, this interview stands out as one of his strongest.
 
Back
Top